ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

A Phase I Expansion Cohort Study Evaluating the Safety and Efficacy of the CHK1 Inhibitor LY2880070 with Low-dose Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma.

Brandon M Huffman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.